Lirum Therapeutics (Lirum Therapeutics) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2024. Start your Free Trial

What is Lirum Therapeutics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Lirum Therapeutics's Free Cash Flow for the three months ended in Dec. 2023 was $0.00 Mil. Lirum Therapeutics's Revenue for the three months ended in Dec. 2023 was $0.00 Mil. Therefore, Lirum Therapeutics's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Lirum Therapeutics's current FCF Yield % is 0.00%.

The historical rank and industry rank for Lirum Therapeutics's FCF Margin % or its related term are showing as below:

LRTX's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -139.09
* Ranked among companies with meaningful FCF Margin % only.

Lirum Therapeutics FCF Margin % Historical Data

The historical data trend for Lirum Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lirum Therapeutics FCF Margin % Chart

Lirum Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

FCF Margin %

Lirum Therapeutics Quarterly Data
	Dec21	Sep22	Dec22	Sep23	Dec23
FCF Margin %	-	-	-	-	-

Competitive Comparison of Lirum Therapeutics's FCF Margin %

For the Biotechnology subindustry, Lirum Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lirum Therapeutics's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lirum Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Lirum Therapeutics's FCF Margin % falls into.

Lirum Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Lirum Therapeutics's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-2.241	/	0
	=	%

Lirum Therapeutics's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0	/	0
	=	%

Lirum Therapeutics FCF Margin % Related Terms

Thank you for viewing the detailed overview of Lirum Therapeutics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Lirum Therapeutics (Lirum Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lirum Therapeutics Inc (NAS:LRTX) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

590 Madison Avenue, 21st Floor, New York, NY, USA, 10022

Website

https://www.lirumtx.com

Lirum Therapeutics Inc is clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases through the acquisition, development, and commercialization of novel drug candidates with compelling mechanisms of action, regulatory pathways, and commercial opportunities. Its product candidate, LX-101, formerly 765IGF-MTX, is a novel, clinical-stage, "next generation," precision-engineered targeted therapy directed to the IGF-1R.

Lirum Therapeutics (Lirum Therapeutics) Headlines

No Headlines